Position in NVS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$18,788
-$1,144,972 QoQ
Shares Held
123
-98.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TIAA TRUST, NATIONAL ASSOCIATION holds $8,956,173 across 9 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,676 | $3,473,293 | |
| 2 | ABBV |
AbbVie Inc.
|
9,611 | $2,418,512 | |
| 3 | AMGN |
Amgen Inc
|
2,536 | $918,336 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
5,082 | $642,059 | |
| 5 | LLY |
ELI LILLY & Co
|
505 | $605,712 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,317 | $554,734 | |
| 7 | PFE |
Pfizer Inc
|
8,240 | $198,419 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,233 | $128,665 |
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,788 | 123 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,163,760 | 8,441 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,116,970 | 8,710 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,002,204 | 8,282 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $944,681 | 8,474 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $766,316 | 7,875 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $840,336 | 7,306 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $745,326 | 7,001 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $759,523 | 7,852 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $624,600 | 6,186 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $724,632 | 7,114 | Shares | Sole | 2023-10-27 | |
| No filing history on record for this holder in this stock. | ||||||